Impact of Empiric Carbapenem Beta-Lactam (CBL) Versus Non-Carbapenem Beta-Lactam (N-CBL) Treatment on Mortality and Microbiological Response Rates for Third-Generation Cephalosporin-Resistant (3GCR) Enterobacteriaceae Bloodstream Infections (BSI)

Impact of Empiric Carbapenem Beta-Lactam (CBL) Versus Non-Carbapenem Beta-Lactam (N-CBL) Treatment on Mortality and Microbiological Response Rates for Third-Generation Cephalosporin-Resistant (3GCR) Enterobacteriaceae Bloodstream Infections (BSI)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open forum infectious diseases 2016-12, Vol.3 (suppl_1)
Hauptverfasser: Kirejczyk, Melissa, Jonchhe, Srijana, Giancola, Stephanie E., Hogan, Michael, Ahn, Sunwoo, Mahoney, Monica V., Snyder, Graham M., Beaulac, Kirthana R., Hirsch, Elizabeth B.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue suppl_1
container_start_page
container_title Open forum infectious diseases
container_volume 3
creator Kirejczyk, Melissa
Jonchhe, Srijana
Giancola, Stephanie E.
Hogan, Michael
Ahn, Sunwoo
Mahoney, Monica V.
Snyder, Graham M.
Beaulac, Kirthana R.
Hirsch, Elizabeth B.
description
doi_str_mv 10.1093/ofid/ofw172.755
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ofid_ofw172_755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_ofid_ofw172_755</sourcerecordid><originalsourceid>FETCH-LOGICAL-c815-9c3ab4268304ac5b6d62f686ba2d75752820deb56aeac48b776866feb5c4fe0f3</originalsourceid><addsrcrecordid>eNp1kUFPwzAMhSsEEgg4c_VxOwTSdmm7I6vGmDRAGhPXyk0dCGqTKglC_HHOZMCBCxfbsp8_2XpJcpHyy5TP8yurdBfDe1pml6UQB8lJlmcVq-aiPPxTHyfn3r9yztOUC17OT5LP9TCiDGAVLIdROy2hRtfiSIYGWFBAtolzHGBSLzZTeCLn3zzcW8P-092zb-XOEYaBTGQbuLMuYK_DB6Dp4E5LZ1tte_usJfawJT9a4wm2GMiDsg52L9p1bBXpDoOOhJrGF-xtFDptWNzQPmCET_JVvZ3C0gSKzHgCOY2SkGDRW9v5EM8YYG0UyT3Hw2TxuJ6eJUcKe0_nv_k02d0sd_Ut2zys1vX1hskqFWwuc2xnWVHlfIZStEVXZKqoihazrhSlyKqMd9SKAgnlrGrLMg4LFTtypoir_DS5-sHGf713pJrR6QHdR5PyZm9cszeu-TGuicblX5KrkVk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impact of Empiric Carbapenem Beta-Lactam (CBL) Versus Non-Carbapenem Beta-Lactam (N-CBL) Treatment on Mortality and Microbiological Response Rates for Third-Generation Cephalosporin-Resistant (3GCR) Enterobacteriaceae Bloodstream Infections (BSI)</title><source>DOAJ Directory of Open Access Journals</source><source>Access via Oxford University Press (Open Access Collection)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Kirejczyk, Melissa ; Jonchhe, Srijana ; Giancola, Stephanie E. ; Hogan, Michael ; Ahn, Sunwoo ; Mahoney, Monica V. ; Snyder, Graham M. ; Beaulac, Kirthana R. ; Hirsch, Elizabeth B.</creator><creatorcontrib>Kirejczyk, Melissa ; Jonchhe, Srijana ; Giancola, Stephanie E. ; Hogan, Michael ; Ahn, Sunwoo ; Mahoney, Monica V. ; Snyder, Graham M. ; Beaulac, Kirthana R. ; Hirsch, Elizabeth B.</creatorcontrib><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofw172.755</identifier><language>eng</language><ispartof>Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Kirejczyk, Melissa</creatorcontrib><creatorcontrib>Jonchhe, Srijana</creatorcontrib><creatorcontrib>Giancola, Stephanie E.</creatorcontrib><creatorcontrib>Hogan, Michael</creatorcontrib><creatorcontrib>Ahn, Sunwoo</creatorcontrib><creatorcontrib>Mahoney, Monica V.</creatorcontrib><creatorcontrib>Snyder, Graham M.</creatorcontrib><creatorcontrib>Beaulac, Kirthana R.</creatorcontrib><creatorcontrib>Hirsch, Elizabeth B.</creatorcontrib><title>Impact of Empiric Carbapenem Beta-Lactam (CBL) Versus Non-Carbapenem Beta-Lactam (N-CBL) Treatment on Mortality and Microbiological Response Rates for Third-Generation Cephalosporin-Resistant (3GCR) Enterobacteriaceae Bloodstream Infections (BSI)</title><title>Open forum infectious diseases</title><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kUFPwzAMhSsEEgg4c_VxOwTSdmm7I6vGmDRAGhPXyk0dCGqTKglC_HHOZMCBCxfbsp8_2XpJcpHyy5TP8yurdBfDe1pml6UQB8lJlmcVq-aiPPxTHyfn3r9yztOUC17OT5LP9TCiDGAVLIdROy2hRtfiSIYGWFBAtolzHGBSLzZTeCLn3zzcW8P-092zb-XOEYaBTGQbuLMuYK_DB6Dp4E5LZ1tte_usJfawJT9a4wm2GMiDsg52L9p1bBXpDoOOhJrGF-xtFDptWNzQPmCET_JVvZ3C0gSKzHgCOY2SkGDRW9v5EM8YYG0UyT3Hw2TxuJ6eJUcKe0_nv_k02d0sd_Ut2zys1vX1hskqFWwuc2xnWVHlfIZStEVXZKqoihazrhSlyKqMd9SKAgnlrGrLMg4LFTtypoir_DS5-sHGf713pJrR6QHdR5PyZm9cszeu-TGuicblX5KrkVk</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Kirejczyk, Melissa</creator><creator>Jonchhe, Srijana</creator><creator>Giancola, Stephanie E.</creator><creator>Hogan, Michael</creator><creator>Ahn, Sunwoo</creator><creator>Mahoney, Monica V.</creator><creator>Snyder, Graham M.</creator><creator>Beaulac, Kirthana R.</creator><creator>Hirsch, Elizabeth B.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161201</creationdate><title>Impact of Empiric Carbapenem Beta-Lactam (CBL) Versus Non-Carbapenem Beta-Lactam (N-CBL) Treatment on Mortality and Microbiological Response Rates for Third-Generation Cephalosporin-Resistant (3GCR) Enterobacteriaceae Bloodstream Infections (BSI)</title><author>Kirejczyk, Melissa ; Jonchhe, Srijana ; Giancola, Stephanie E. ; Hogan, Michael ; Ahn, Sunwoo ; Mahoney, Monica V. ; Snyder, Graham M. ; Beaulac, Kirthana R. ; Hirsch, Elizabeth B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c815-9c3ab4268304ac5b6d62f686ba2d75752820deb56aeac48b776866feb5c4fe0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kirejczyk, Melissa</creatorcontrib><creatorcontrib>Jonchhe, Srijana</creatorcontrib><creatorcontrib>Giancola, Stephanie E.</creatorcontrib><creatorcontrib>Hogan, Michael</creatorcontrib><creatorcontrib>Ahn, Sunwoo</creatorcontrib><creatorcontrib>Mahoney, Monica V.</creatorcontrib><creatorcontrib>Snyder, Graham M.</creatorcontrib><creatorcontrib>Beaulac, Kirthana R.</creatorcontrib><creatorcontrib>Hirsch, Elizabeth B.</creatorcontrib><collection>CrossRef</collection><jtitle>Open forum infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirejczyk, Melissa</au><au>Jonchhe, Srijana</au><au>Giancola, Stephanie E.</au><au>Hogan, Michael</au><au>Ahn, Sunwoo</au><au>Mahoney, Monica V.</au><au>Snyder, Graham M.</au><au>Beaulac, Kirthana R.</au><au>Hirsch, Elizabeth B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Empiric Carbapenem Beta-Lactam (CBL) Versus Non-Carbapenem Beta-Lactam (N-CBL) Treatment on Mortality and Microbiological Response Rates for Third-Generation Cephalosporin-Resistant (3GCR) Enterobacteriaceae Bloodstream Infections (BSI)</atitle><jtitle>Open forum infectious diseases</jtitle><date>2016-12-01</date><risdate>2016</risdate><volume>3</volume><issue>suppl_1</issue><issn>2328-8957</issn><eissn>2328-8957</eissn><doi>10.1093/ofid/ofw172.755</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2328-8957
ispartof Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)
issn 2328-8957
2328-8957
language eng
recordid cdi_crossref_primary_10_1093_ofid_ofw172_755
source DOAJ Directory of Open Access Journals; Access via Oxford University Press (Open Access Collection); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
title Impact of Empiric Carbapenem Beta-Lactam (CBL) Versus Non-Carbapenem Beta-Lactam (N-CBL) Treatment on Mortality and Microbiological Response Rates for Third-Generation Cephalosporin-Resistant (3GCR) Enterobacteriaceae Bloodstream Infections (BSI)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T02%3A20%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Empiric%20Carbapenem%20Beta-Lactam%20(CBL)%20Versus%20Non-Carbapenem%20Beta-Lactam%20(N-CBL)%20Treatment%20on%20Mortality%20and%20Microbiological%20Response%20Rates%20for%20Third-Generation%20Cephalosporin-Resistant%20(3GCR)%20Enterobacteriaceae%20Bloodstream%20Infections%20(BSI)&rft.jtitle=Open%20forum%20infectious%20diseases&rft.au=Kirejczyk,%20Melissa&rft.date=2016-12-01&rft.volume=3&rft.issue=suppl_1&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofw172.755&rft_dat=%3Ccrossref%3E10_1093_ofid_ofw172_755%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true